1. Home
  2. AMTD vs IBIO Comparison

AMTD vs IBIO Comparison

Compare AMTD & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMTD IDEA Group each representing six (6)

AMTD

AMTD IDEA Group each representing six (6)

N/A

Current Price

$0.73

Market Cap

71.2M

Sector

N/A

ML Signal

N/A

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.26

Market Cap

83.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMTD
IBIO
Founded
2003
2008
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
71.2M
83.5M
IPO Year
2019
2009

Fundamental Metrics

Financial Performance
Metric
AMTD
IBIO
Price
$0.73
$1.26
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
8.0K
547.7K
Earning Date
04-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
81.71
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$1.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.71
$0.77
52 Week High
$1.65
$3.82

Technical Indicators

Market Signals
Indicator
AMTD
IBIO
Relative Strength Index (RSI) 45.27 42.31
Support Level $0.71 $1.21
Resistance Level $0.80 $1.52
Average True Range (ATR) 0.04 0.06
MACD -0.00 -0.00
Stochastic Oscillator 41.87 45.00

Price Performance

Historical Comparison
AMTD
IBIO

About AMTD AMTD IDEA Group each representing six (6)

AMTD IDEA Group is a diversified institution and digital solutions conglomerate group, connecting companies and investors with world-wide markets. The group operates its businesses in five reportable and operating segments: capital market solutions segment, digital solutions and other services segment, media and entertainment segment, hotel operations, hospitality and VIP services segment, and strategic investment segment. The group generates the majority of its revenue from the strategic investment segment that engages in proprietary investments and management of world-wide investment portfolio (including listed and unlisted equity shares investments and movie rights investments). Its geographic areas are China, Europe, America, and Southeast Asia.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: